Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
46.53
+0.12 (0.26%)
Nov 20, 2026, 4:00 PM EST - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $3.42 billion as of November 20, 2026. It is the 4,463rd most valuable company in the world and the 1,375th biggest in the United States. Its market cap has increased by 161.09% in one year.
Market Cap
3.42B
Enterprise Value
2.54B
1-Year Change
161.09%
Global Rank
Country Rank
#1,375 United States
Category
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $3.42B, an increase of 251.57%. That is a compound annual growth rate of 39.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.42B | 274.68% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 3.78B |
| Xenon Pharmaceuticals | 3.69B |
| Viridian Therapeutics | 3.57B |
| Relay Therapeutics | 3.52B |
| Disc Medicine | 3.47B |
| Parabilis Medicines | 3.46B |
| Arcutis Biotherapeutics | 3.44B |
| AbCellera Biologics | 3.42B |